Intra-familial clinical heterogeneity: absence of genotype-phenotype correlation in primary hyperoxaluria type 1 in Israel
- PMID: 15961946
- DOI: 10.1159/000086357
Intra-familial clinical heterogeneity: absence of genotype-phenotype correlation in primary hyperoxaluria type 1 in Israel
Abstract
Background/aims: Primary hyperoxaluria type 1 (PH1) is caused by the deficiency of the liver enzyme alanine:glyoxylate aminotransferase which results in increased synthesis and excretion of oxalate. The clinical manifestations of PH1 are heterogeneous with respect to the age of onset and rate of progression. The aim of this study was to investigate possible relationships between a given genotype, the biochemical profile and the clinical phenotype.
Methods: We conducted a study of 56 patients from 22 families with PH1 from Israel. The clinical and biochemical data were compiled and the genotype was determined for each family.
Results: The prevalent phenotype was of early onset with progression to end-stage renal disease during the first decade of life. Fifteen PH1-causing mutations were detected in 21 families: 10 were first described in this patient population. Marked intra-familial clinical heterogeneity was noted, meaning that there was no correlation between a given genotype and the phenotype.
Conclusions: The clinical course of patients with PH1 is not dictated primarily by its genotype. Other genetic and/or environmental factors play a role in determining the ultimate phenotype.
Similar articles
-
Genetic heterogeneity in primary hyperoxaluria type 1: impact on diagnosis.Mol Genet Metab. 2004 Sep-Oct;83(1-2):38-46. doi: 10.1016/j.ymgme.2004.08.009. Mol Genet Metab. 2004. PMID: 15464418 Review.
-
Mutation spectrum of primary hyperoxaluria type 1 in Tunisia: implication for diagnosis in North Africa.Gene. 2013 Sep 15;527(1):316-20. doi: 10.1016/j.gene.2013.06.023. Epub 2013 Jun 25. Gene. 2013. PMID: 23810941
-
A double mutation in AGXT gene in families with primary hyperoxaluria type 1.Gene. 2013 Dec 1;531(2):451-6. doi: 10.1016/j.gene.2013.08.083. Epub 2013 Sep 5. Gene. 2013. PMID: 24012869
-
Primary hyperoxaluria: genotype-phenotype correlation.J Nephrol. 2003 Mar-Apr;16(2):297-309. J Nephrol. 2003. PMID: 12768081 Review.
-
Evidence of true genotype-phenotype correlation in primary hyperoxaluria type 1.Kidney Int. 2010 Mar;77(5):383-5. doi: 10.1038/ki.2009.471. Kidney Int. 2010. PMID: 20150937
Cited by
-
Rapid profiling of disease alleles using a tunable reporter of protein misfolding.Genetics. 2012 Nov;192(3):831-42. doi: 10.1534/genetics.112.143750. Epub 2012 Aug 24. Genetics. 2012. PMID: 22923379 Free PMC article.
-
Identification of compound heterozygous patients with primary hyperoxaluria type 1: clinical evaluations and in silico investigations.BMC Nephrol. 2017 Oct 2;18(1):303. doi: 10.1186/s12882-017-0719-y. BMC Nephrol. 2017. PMID: 28969594 Free PMC article.
-
Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice.Clin J Am Soc Nephrol. 2014 Mar;9(3):468-77. doi: 10.2215/CJN.06820613. Epub 2014 Jan 2. Clin J Am Soc Nephrol. 2014. PMID: 24385516 Free PMC article. Clinical Trial.
-
Hereditary causes of kidney stones and chronic kidney disease.Pediatr Nephrol. 2013 Oct;28(10):1923-42. doi: 10.1007/s00467-012-2329-z. Epub 2013 Jan 20. Pediatr Nephrol. 2013. PMID: 23334384 Free PMC article. Review.
-
Improved Outcome of Infantile Oxalosis Over Time in Europe: Data From the OxalEurope Registry.Kidney Int Rep. 2022 Apr 20;7(7):1608-1618. doi: 10.1016/j.ekir.2022.04.012. eCollection 2022 Jul. Kidney Int Rep. 2022. PMID: 35812297 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases